Biomarkers of natural and vaccine immunity against HIV

Biomarkers in Medicine

Volumn 5, Issue 2, 2011, Pages 113-116

  Keane, Niamh ^a   John, Mina ^a,b  

^a MURDOCH UNIVERSITY   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

CD8 T cell; escape; HIV; polyfunctional; vaccine

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; VIRUS PROTEIN;

ACTIVE IMMUNIZATION; ADENOVIRUS 5; CD8+ T LYMPHOCYTE; CYTOTOXICITY; DRUG EFFICACY; GENETIC ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION CONTROL; NONHUMAN; PASSIVE IMMUNIZATION; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; VACCINATION; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

AIDS VACCINES; ANTIBODY FORMATION; BIOLOGICAL MARKERS; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE;

EID: 79953874187     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/bmm.11.23     Document Type: Review

References (19)

1. Plotkin SA: Correlates of protection induced by vaccination. Clin. Vaccine Immunol. 17(6), 1055-1065 (2010).
2. Mascola JR, Stiegler G, VanCott TC et al.: Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6(2), 207-210 (2000). (Pubitemid 30082367)
3. Haynes BF, Moody MA, Liao HX, Verkoczy L, Tomaras GD: B cell responses to HIV-1 infection and vaccination: pathways to preventing infection. Trends Mol. Med. 17(2), 108-116 (2011)
4. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S et al.; MOPH-TAVEG Investigators: ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J Med. 361(23), 2209-2220 (2009).
5. Buchbinder SP, Mehrotra DV, Duerr A et al.; Step Study Protocol Team: Effcacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372(9653), 1881-1893 (2008).
6. McElrath MJ, De Rosa SC, Moodie Z et al.; Step Study Protocol Team: HIV-1 vaccine-induced immunity in the test-of-concept Step study: a case-cohort analysis. Lancet 372(9653), 1894-1905 (2008).
7. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD; International HIV Controllers Study: The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330(6010), 1551-1557 (2010).
8. Fellay J: Host genome infuences on HIV-1 disease. Antivir. Ther. 14(6), 731-738 (2009).
9. Brumme Z, John M, Carlson JM et al.: HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. PLOS One 4(8), e6687 (2009).
10. Goonetilke N, Liu MK, Salazar-Gonzalez JF et al.: The frst T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J. Exp. Med. 206(6), 1253-1272 (2009).
11. Addo MM, Yu XG, Rathod A et al.: Comprehensive epitope analysis of human immunodefciency virus type-1 (HIV-1)-specifc T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77(3), 2081-2092 (2003). (Pubitemid 36110021)
12. + T cells. Blood 107, 4781-4789 (2006). (Pubitemid 43882629)
13. Hersperger AR, Pereyra F, Nason M et al.: Perforin expression directly ex vivo by HIV-specifc CD8 T-cells is a correlate of HIV elite control. PLoS Pathog. 6(5), e1000917 (2010).
14. + T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29(6), 1009-1021 (2008).
15. Harari A, Enders FB, Cellerai C, Bart PA, Pantaleo G: Distinct profles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure. J. Virol. 83(7), 2862-2871 (2009).
16. Ferrari G, Korber B, Goonetilleke N et al.: Relationship between functional profle of HIV-1 specifc CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 Infection. PLoS Pathog. 7(2), e1001273 (2011).
17. Keane N, Roberts S, Laird R et al.: Selection of higher avidity HLA-restricted T cell responses as a viral adaptationstrategy Presented at: AIDS Vaccine. Paris, France, 19-22 October 2009.
18. Harari A, Cellerai C, Enders FB et al.: Skewed association of polyfunctional antigen-specifc CD8 T cell populations with HLA-B genotype. Proc Natl Acad. Sci. USA 104(41), 16233-16238 (2007). (Pubitemid 350099390)
19. Fellay J, Frahm N, Shianna KV et al.: Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the Step trial. J. Infect. Dis. 203(6), 773-779 (2011).